CIK 0001541157 · Non-accelerated filer<br>Smaller reporting company
Akari Therapeutics Plc
Sign in to watch- Ticker
- AKTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- EIN
- 981034922
- Phone
- (929) 274-7510
- Business address
- 401 EAST JACKSON STREET, SUITE 3300, TAMPA, FL, 33602
- Former names
- Celsus Therapeutics Plc., Morria Biopharmaceuticals PLC
- SC 13D Stake Beneficial Ownership Report
- 8-K Event Executive or director change
- 4 Grant or award Director acquired 1,326,258,000 shares (grant or award)
- 4 Grant or award Director acquired 1,326,258,000 shares (grant or award)
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Exit or restructuring costs · Executive or director change
- 4 Grant or award Interim CFO acquired 158,473,915 shares (grant or award)
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Executive or director change · Other events
- 4 Grant or award Chief Executive Officer acquired 479,569,892 shares (grant or award)
- 8-K Event Delisting notice
- 8-K Event Results of operations
- 10-K Report Annual Report
- 425 Deal Prospectus/Communication re Business Combination
- 8-K Event Material agreement · Unregistered share sale
Page 11 of 38 · 746 filings